About Autem Therapeutics
Autem Therapeutics is a company based in Hanover (United States) founded in 2022 by Frederico Costa and Michael Choukas.. Autem Therapeutics has raised $11.5 million across 2 funding rounds from investors including Zentynel and Spectra Investments. The company has 10 employees as of December 31, 2023. Autem Therapeutics offers products and services including AutEMsys TM. Autem Therapeutics operates in a competitive market with competitors including Sequana Medical, Novocure, QV Bioelectronics, Ablatus Therapeutics and Mirai Medical, among others.
- Headquarter Hanover, United States
- Employees 10 as on 31 Dec, 2023
- Founders Frederico Costa, Michael Choukas
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Autem
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.5 M (USD)
in 2 rounds
-
Latest Funding Round
$1.5 M (USD), Series A
Feb 29, 2024
-
Investors
Zentynel
& 1 more
-
Employee Count
10
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Autem Therapeutics
Autem Therapeutics offers a comprehensive portfolio of products and services, including AutEMsys TM. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers electromagnetic frequencies to balance energy in cancer cells.
Unlock access to complete
Funding Insights of Autem Therapeutics
Autem Therapeutics has successfully raised a total of $11.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.5 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $1.5M
-
First Round
First Round
(06 Jun 2022)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Series A - Autem Therapeutics | Valuation |
investors |
|
| Jun, 2022 | Amount | Series A - Autem Therapeutics | Valuation | Zentynel |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Autem Therapeutics
Autem Therapeutics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Zentynel and Spectra Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Zentynel is focused on investing in biotechnology companies.
|
Founded Year | Domain | Location | |
|
Diversified asset management services are offered to clients in Brazil.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Autem Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Autem Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Autem Therapeutics Comparisons
Competitors of Autem Therapeutics
Autem Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sequana Medical, Novocure, QV Bioelectronics, Ablatus Therapeutics and Mirai Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for solid tumors are developed via Tumor Treating Fields.
|
|
| domain | founded_year | HQ Location |
Electrotherapy devices for brain tumor treatment are manufactured.
|
|
| domain | founded_year | HQ Location |
Develops innovative devices for bimodal electric tissue ablation.
|
|
| domain | founded_year | HQ Location |
Mirai Medical is focused on transforming gastrointestinal disease treatment.
|
|
| domain | founded_year | HQ Location |
Liver dialysis devices for treating cirrhosis and failure are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Autem Therapeutics
When was Autem Therapeutics founded?
Autem Therapeutics was founded in 2022.
Where is Autem Therapeutics located?
Autem Therapeutics is headquartered in Hanover, United States. It is registered at Hanover, New Hampshire, United States.
Who is the current CEO of Autem Therapeutics?
Michael Choukas is the current CEO of Autem Therapeutics. They have also founded this company.
Is Autem Therapeutics a funded company?
Autem Therapeutics is a funded company, having raised a total of $11.5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Jun 06, 2022.
How many employees does Autem Therapeutics have?
As of Dec 31, 2023, the latest employee count at Autem Therapeutics is 10.
What does Autem Therapeutics do?
Autem Therapeutics was founded in 2022 and is based in Hanover, United States. Bioelectric technology and oncology therapeutics are developed by the company. A bioelectric platform called AutEMsys is being created to provide personalized, amplitude-modulated electromagnetic frequencies. These are targeted at hepatocellular carcinoma and other solid tumor cancers. Operations focus on advancing non-invasive treatment options in the biotechnology sector.
Who are the top competitors of Autem Therapeutics?
Autem Therapeutics's top competitors include Sequana Medical, Novocure and QV Bioelectronics.
What products or services does Autem Therapeutics offer?
Autem Therapeutics offers AutEMsys TM.
Who are Autem Therapeutics's investors?
Autem Therapeutics has 2 investors. Key investors include Zentynel, and Spectra Investments.